| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/WNAN.1440 |
| P698 | PubMed publication ID | 27863136 |
| P2093 | author name string | Ran Chen | |
| Jim E Riviere | |||
| P2860 | cites work | Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration | Q23909704 |
| Estimating the effective density of engineered nanomaterials for in vitro dosimetry | Q23913174 | ||
| Prediction of dermal absorption from complex chemical mixtures: incorporation of vehicle effects and interactions into a QSPR framework | Q23913877 | ||
| A system coefficient approach for quantitative assessment of the solvent effects on membrane absorption from chemical mixtures | Q23923862 | ||
| Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity | Q39143913 | ||
| Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface | Q39207806 | ||
| Modeling biological activities of nanoparticles | Q39265233 | ||
| Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake | Q39398202 | ||
| Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier | Q39420614 | ||
| Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. | Q39447143 | ||
| Size-dependent interaction of silica nanoparticles with lysozyme and bovine serum albumin proteins. | Q39684179 | ||
| Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles | Q39742676 | ||
| Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles | Q39787205 | ||
| Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. | Q40024022 | ||
| Physiologically Based Pharmacokinetic Model for Long-Circulating Inorganic Nanoparticles. | Q40103336 | ||
| Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. | Q40139914 | ||
| Protein adsorption induced bridging flocculation: the dominant entropic pathway for nano-bio complexation | Q40150291 | ||
| Interaction of lipid vesicle with silver nanoparticle-serum albumin protein corona. | Q40556299 | ||
| Predicting Toxicities of Diverse Chemical Pesticides in Multiple Avian Species Using Tree-Based QSAR Approaches for Regulatory Purposes | Q40754583 | ||
| Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties. | Q40955960 | ||
| Surface chemistry and serum type both determine the nanoparticle-protein corona | Q40970781 | ||
| Comprehensive spectroscopic studies on the interaction of biomolecules with surfactant detached multi-walled carbon nanotubes. | Q41364754 | ||
| Dendrimer-Fullerenol Soft-Condensed Nanoassembly | Q41828400 | ||
| Probing of the assembly structure and dynamics within nanoparticles during interaction with blood proteins. | Q41949821 | ||
| Quantum dot DNA bioconjugates: attachment chemistry strongly influences the resulting composite architecture | Q42161416 | ||
| Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling | Q42462263 | ||
| Comparison of nanotube-protein corona composition in cell culture media. | Q43071119 | ||
| Role of nanoparticle geometry in endocytosis: laying down to stand up. | Q43659505 | ||
| Nanoparticle surface characterization and clustering through concentration-dependent surface adsorption modeling | Q43876219 | ||
| Modeling the primary size effects of citrate-coated silver nanoparticles on their ion release kinetics | Q43973460 | ||
| Surface and size effects on cell interaction of gold nanoparticles with both phagocytic and nonphagocytic cells | Q44736802 | ||
| Quantitative nanostructure-activity relationship modeling | Q28385022 | ||
| An integrated approach for the in vitro dosimetry of engineered nanomaterials | Q28386114 | ||
| Implications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterials | Q28389056 | ||
| Multi-walled carbon nanotube instillation impairs pulmonary function in C57BL/6 mice | Q28391783 | ||
| Advanced computational modeling for in vitro nanomaterial dosimetry | Q28392035 | ||
| Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation | Q28392757 | ||
| Buoyant Nanoparticles: Implications for Nano-Biointeractions in Cellular Studies | Q28392986 | ||
| Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry | Q28397068 | ||
| Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations | Q28533556 | ||
| Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles | Q28651740 | ||
| Physicochemical properties of nanoparticles regulate translocation across pulmonary surfactant monolayer and formation of lipoprotein corona | Q29248541 | ||
| Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases | Q29617578 | ||
| Effect of fullerenol surface chemistry on nanoparticle binding-induced protein misfolding. | Q30363665 | ||
| Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. | Q30489569 | ||
| Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. | Q31134669 | ||
| Time evolution of the nanoparticle protein corona. | Q33606003 | ||
| An index for characterization of nanomaterials in biological systems. | Q33658455 | ||
| Direct observation of a single nanoparticle-ubiquitin corona formation | Q33683190 | ||
| Size and surface functionalization of iron oxide nanoparticles influence the composition and dynamic nature of their protein corona | Q34160421 | ||
| Formation and cell translocation of carbon nanotube-fibrinogen protein corona | Q34307940 | ||
| Transferrin coated nanoparticles: study of the bionano interface in human plasma | Q34351046 | ||
| Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles | Q34444404 | ||
| ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies | Q34451016 | ||
| Effects of surface functional groups on the formation of nanoparticle-protein corona | Q34557912 | ||
| Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption | Q34646392 | ||
| Noninvasive MRI-SERS imaging in living mice using an innately bimodal nanomaterial | Q34807017 | ||
| Differently environment stable bio-silver nanoparticles: study on their optical enhancing and antibacterial properties | Q35018708 | ||
| Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles | Q35092075 | ||
| The effect of nanoparticle size on the probability to cross the blood-brain barrier: an in-vitro endothelial cell model | Q35177868 | ||
| Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging | Q35558668 | ||
| Mapping the surface adsorption forces of nanomaterials in biological systems | Q35569111 | ||
| Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes | Q44867805 | ||
| Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model | Q44875957 | ||
| Organ-Specific and Size-Dependent Ag Nanoparticle Toxicity in Gills and Intestines of Adult Zebrafish | Q45172669 | ||
| Non-functionalized silver nanoparticles for a localized surface plasmon resonance-based glucose sensor. | Q46023104 | ||
| Dissolution, agglomerate morphology, and stability limits of protein-coated silver nanoparticles | Q46850488 | ||
| Detection and characterization of silver nanoparticles and dissolved species of silver in culture medium and cells by AsFlFFF-UV-Vis-ICPMS: application to nanotoxicity tests | Q46978104 | ||
| Computational and experimental characterizations of silver nanoparticle-apolipoprotein biocorona. | Q46989521 | ||
| Adsorption of organic acids on TiO2 nanoparticles: effects of pH, nanoparticle size, and nanoparticle aggregation. | Q47230602 | ||
| Protein corona formation for nanomaterials and proteins of a similar size: hard or soft corona? | Q47259700 | ||
| Size and ζ-Potential Measurement of Silica Nanoparticles in Serum Using Tunable Resistive Pulse Sensing. | Q47326125 | ||
| Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner | Q47350894 | ||
| Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles | Q47352466 | ||
| The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. | Q47353707 | ||
| Aggregation and dissolution of 4 nm ZnO nanoparticles in aqueous environments: influence of pH, ionic strength, size, and adsorption of humic acid. | Q47380687 | ||
| Artificial chaperones based on mixed shell polymeric micelles: insight into the mechanism of the interaction of the chaperone with substrate proteins using Förster resonance energy transfer | Q47569244 | ||
| POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers. | Q48659140 | ||
| Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer. | Q50887393 | ||
| Protein-nanoparticle interactions: the effects of surface compositional and structural heterogeneity are scale dependent. | Q50890351 | ||
| Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules. | Q50909092 | ||
| Multi-residue determination of pesticides in water using multi-walled carbon nanotubes solid-phase extraction and gas chromatography-mass spectrometry. | Q50935860 | ||
| Probing the influence of citrate-capped gold nanoparticles on an amyloidogenic protein. | Q50957448 | ||
| Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. | Q50966041 | ||
| Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. | Q51667178 | ||
| Statistical external validation and consensus modeling: a QSPR case study for Koc prediction. | Q51936057 | ||
| Understanding the degradation pathway of the pesticide, chlorpyrifos by noble metal nanoparticles. | Q52732917 | ||
| The Evolution of the Protein Corona around Nanoparticles: A Test Study | Q55167439 | ||
| Understanding and modulating the competitive surface-adsorption of proteins through coarse-grained molecular dynamics simulations | Q55407194 | ||
| Studies on the effect of AgNP binding on α-amylase structure of porcine pancreas and Bacillus subtilis by multi-spectroscopic methods | Q57173012 | ||
| Contrasting Effects of Nanoparticle Binding on Protein Denaturation | Q57186965 | ||
| Thermostability and reversibility of silver nanoparticle–protein binding | Q57829440 | ||
| Binding of cytoskeletal proteins with silver nanoparticles | Q57829444 | ||
| Effects of Surface Compositional and Structural Heterogeneity on Nanoparticle–Protein Interactions: Different Protein Configurations | Q57910102 | ||
| Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers | Q57947040 | ||
| Large Protein Absorptions from Small Changes on the Surface of Nanoparticles | Q57967160 | ||
| Docking of Ubiquitin to Gold Nanoparticles | Q57975279 | ||
| Effect of membrane charge density on the protein corona of cationic liposomes: Interplay between cationic charge and surface area | Q58207856 | ||
| Synthesis of 5-Fluorouracil conjugated LaF3:Tb3+/PEG-COOH nanoparticles and its studies on the interaction with bovine serum albumin: spectroscopic approach | Q58896788 | ||
| Effect of Adsorbed Proteins on the Wettability of Hydrophilic and Hydrophobic Solids | Q59084387 | ||
| Quantitative proteomics analysis of adsorbed plasma proteins classifies nanoparticles with different surface properties and size | Q35655227 | ||
| Evaluation of Toxicity Ranking for Metal Oxide Nanoparticles via an in Vitro Dosimetry Model | Q35748892 | ||
| Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles | Q35839945 | ||
| Quantification of nanoparticle pesticide adsorption: computational approaches based on experimental data | Q35988896 | ||
| Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages | Q36048542 | ||
| Chemical transformations of nanosilver in biological environments | Q36429033 | ||
| Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties | Q36472643 | ||
| Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition | Q36499539 | ||
| Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles | Q36933014 | ||
| Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy | Q36933043 | ||
| Competitive binding of natural amphiphiles with graphene derivatives | Q37039630 | ||
| Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform | Q37069877 | ||
| Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues | Q37153923 | ||
| Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? | Q37172031 | ||
| Surface characterization of nanomaterials and nanoparticles: Important needs and challenging opportunities | Q37406394 | ||
| Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier. | Q37429043 | ||
| Toward the development of "nano-QSARs": advances and challenges | Q37605014 | ||
| Physiologically based pharmacokinetic modeling of nanoparticles | Q37800093 | ||
| Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential. | Q38060983 | ||
| Pharmacokinetics of metallic nanoparticles. | Q38260360 | ||
| Corona-directed nucleic acid delivery into hepatic stellate cells for liver fibrosis therapy. | Q38301712 | ||
| Influence of carbon nanomaterial defects on the formation of protein corona | Q38371536 | ||
| Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties | Q38793876 | ||
| Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment. | Q38810378 | ||
| Stealth effect of biomolecular corona on nanoparticle uptake by immune cells. | Q38834769 | ||
| Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide | Q38881377 | ||
| Protein corona of nanoparticles: distinct proteins regulate the cellular uptake | Q38897071 | ||
| Surface chemistry of photoluminescent F8BT conjugated polymer nanoparticles determines protein corona formation and internalization by phagocytic cells. | Q38919815 | ||
| A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles | Q38933494 | ||
| Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release | Q39023812 | ||
| Biologically inspired stealth peptide-capped gold nanoparticles | Q39028526 | ||
| Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/DNA nanoparticles | Q39061880 | ||
| Revealing the binding structure of the protein corona on gold nanorods using synchrotron radiation-based techniques: understanding the reduced damage in cell membranes | Q39064712 | ||
| Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology | Q39093144 | ||
| P433 | issue | 3 | |
| P921 | main subject | nanomaterial | Q967847 |
| P577 | publication date | 2016-11-08 | |
| P1433 | published in | Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology | Q24056192 |
| P1476 | title | Biological and environmental surface interactions of nanomaterials: characterization, modeling, and prediction | |
| P478 | volume | 9 |
| Q90473739 | An analytical approach for quantifying the influence of nanoparticle polydispersity on cellular delivered dose |
| Q46411496 | Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives. |
| Q89801078 | Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach |
| Q57274162 | Minimum information reporting in bio-nano experimental literature |
| Q46827035 | NanoEHS beyond Toxicity - Focusing on Biocorona |
| Q59800287 | Nanotechnology and multipotent adult progenitor cells in Reparative Medicine: therapeutic perspectives |
| Q64231487 | Physiologically based mathematical models of nanomaterials for regulatory toxicology: A review |
| Q64066187 | SF-1 mediates reproductive toxicity induced by Cerium oxide nanoparticles in male mice |
Search more.